About this trial
The goal of this clinical trial is to evaluate the feasibility of a cardiac pre-hab program for patients with blocked arteries (CTO) who are referred for PCI treatment. The main questions it aims to answer are:
Can the pre-hab program improve patients\' functional capacity before PCI? Does the pre-hab program impact the need for PCI based on improvements in patients\' health?
Participants will:
Undergo an initial assessment including a physical exam, medication history, quality of life questionnaires, and blood work.
Complete a 6-month cardiac rehabilitation program. Have repeat assessments to evaluate improvements and determine if PCI is still needed.
If PCI is performed, be assessed again one month later for functional capacity improvements.
If PCI is not needed after 6 months, participants will be followed virtually for an additional 5 months.
Eligibility criteria
Qualifiers
The presence of a chronic total occlusion in at least one major coronary artery (diameter ≥ 2.5mm).
Angina or anginal-equivalent symptoms and
Ischemia or viability in the CTO territory
Patient aged ≥18 years of age.
Disqualifiers
Inability or refusal to participate in the study's cardiac rehabilitation program.
Participation in CR program in the last 1 year.
Life expectancy of < 12 months due to non-cardiovascular comorbidities.
Anatomy deemed unsuitable for CTO PCI.
Trial design
Treatments tested in this trial
- Cardiac Prehabilitation Program
Treatment groups
Sponsors and collaborators
Luiz Ybarra
Lead sponsor
London Health Sciences Centre
Sponsor institution
Academic Medical Organization of Southwestern Ontario
Collaborator
University of Western Ontario, Canada
Collaborator